Newsroom

Press Releases

Kythera Newsroom

2011 Archive

December 14, 2011
Kythera Biopharmaceuticals Receives Notice of Allowance for Additional U.S. Patent on ATX-101 (Formulations Of Deoxycholic Acid and Salts)

November 7, 2011
Kythera Biopharmaceuticals Presents Long-Term Follow-Up Study Results From Phase 2 Trials With ATX-101

November 2, 2011
KYTHERA Biopharmaceuticals Announces Preliminary Two-Year Follow-Up Study Results and Poster Presentation of Phase 2B Data from Investigational Fat Reduction Drug at ASDS

September 19, 2011
Kythera Biopharmaceuticals Announces $37.4M Financing

March 17, 2011
Kythera Biopharmaceuticals Presents Patient Reported Outcomes from Phase IIB Study with ATX-101 Demonstrating Reduction of Submental Fat

February 22, 2011
Kythera Biopharmaceuticals Presents Positive Data from Phase IIB Study with ATX-101 Demonstrating Reduction of Submental Fat

February 4, 2011
Kythera Biopharmaceuticals Announces Positive Results from Phase IIB Study with ATX-101 Demonstrating Reduction of Submental Fat

January 10, 2011
Kythera and Intendis Announce Initiation of European Phase III Clinical Development Program to Evaluate ATX-101 for Reduction of Submental Fat

January 6, 2011
Kythera Biopharmaceuticals to Present at The 29th Annual J.P. Morgan Healthcare Conference

View Pipeline »

Submental Fat Reduction »